HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) Fundamental Analysis & Valuation

NYSE:HCXY • US4270968476

Current stock price

24.81 USD
-0.14 (-0.58%)
Last:

This HCXY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. HCXY Profitability Analysis

1.1 Basic Checks

  • HCXY had positive earnings in the past year.
  • HCXY had a negative operating cash flow in the past year.
  • HCXY had positive earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: HCXY reported negative operating cash flow in multiple years.
HCXY Yearly Net Income VS EBIT VS OCF VS FCFHCXY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • With a decent Return On Assets value of 7.35%, HCXY is doing good in the industry, outperforming 76.67% of the companies in the same industry.
  • The Return On Equity of HCXY (15.20%) is better than 74.58% of its industry peers.
  • With a decent Return On Invested Capital value of 6.00%, HCXY is doing good in the industry, outperforming 73.75% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for HCXY is in line with the industry average of 7.24%.
Industry RankSector Rank
ROA 7.35%
ROE 15.2%
ROIC 6%
ROA(3y)7.97%
ROA(5y)6.77%
ROE(3y)15.61%
ROE(5y)13.42%
ROIC(3y)6.67%
ROIC(5y)5.93%
HCXY Yearly ROA, ROE, ROICHCXY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • HCXY has a Profit Margin of 63.24%. This is amongst the best in the industry. HCXY outperforms 92.92% of its industry peers.
  • In the last couple of years the Profit Margin of HCXY has declined.
  • HCXY has a better Operating Margin (64.17%) than 96.25% of its industry peers.
  • HCXY's Operating Margin has improved in the last couple of years.
  • HCXY's Gross Margin of 80.62% is amongst the best of the industry. HCXY outperforms 85.42% of its industry peers.
  • HCXY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 64.17%
PM (TTM) 63.24%
GM 80.62%
OM growth 3Y3.15%
OM growth 5Y3.25%
PM growth 3Y26.79%
PM growth 5Y-4.23%
GM growth 3Y0.01%
GM growth 5Y1%
HCXY Yearly Profit, Operating, Gross MarginsHCXY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. HCXY Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, HCXY has more shares outstanding
  • Compared to 5 years ago, HCXY has more shares outstanding
  • Compared to 1 year ago, HCXY has a worse debt to assets ratio.
HCXY Yearly Shares OutstandingHCXY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
HCXY Yearly Total Debt VS Total AssetsHCXY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 1.55, we must say that HCXY is in the distress zone and has some risk of bankruptcy.
  • HCXY's Altman-Z score of 1.55 is fine compared to the rest of the industry. HCXY outperforms 65.00% of its industry peers.
  • A Debt/Equity ratio of 1.03 is on the high side and indicates that HCXY has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.03, HCXY perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z 1.55
ROIC/WACCN/A
WACCN/A
HCXY Yearly LT Debt VS Equity VS FCFHCXY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that HCXY should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.16, HCXY is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • HCXY has a Quick Ratio of 1.16. This is a normal value and indicates that HCXY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of HCXY (1.16) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
HCXY Yearly Current Assets VS Current LiabilitesHCXY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HCXY Growth Analysis

3.1 Past

  • HCXY shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.48%.
  • Measured over the past 5 years, HCXY shows a small growth in Earnings Per Share. The EPS has been growing by 6.52% on average per year.
  • HCXY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.44%.
  • Measured over the past years, HCXY shows a quite strong growth in Revenue. The Revenue has been growing by 13.13% on average per year.
EPS 1Y (TTM)-4.48%
EPS 3Y9.06%
EPS 5Y6.52%
EPS Q2Q%-2.04%
Revenue 1Y (TTM)-13.44%
Revenue growth 3Y18.29%
Revenue growth 5Y13.13%
Sales Q2Q%12.85%

3.2 Future

  • The Earnings Per Share is expected to decrease by -0.22% on average over the next years.
  • The Revenue is expected to grow by 4.28% on average over the next years.
EPS Next Y5.31%
EPS Next 2Y3.42%
EPS Next 3Y-0.22%
EPS Next 5YN/A
Revenue Next Year8.9%
Revenue Next 2Y7.05%
Revenue Next 3Y4.28%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HCXY Yearly Revenue VS EstimatesHCXY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
HCXY Yearly EPS VS EstimatesHCXY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. HCXY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 12.92, which indicates a correct valuation of HCXY.
  • Compared to the rest of the industry, the Price/Earnings ratio of HCXY is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of HCXY to the average of the S&P500 Index (26.17), we can say HCXY is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 12.27, HCXY is valued correctly.
  • HCXY's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.05, HCXY is valued a bit cheaper.
Industry RankSector Rank
PE 12.92
Fwd PE 12.27
HCXY Price Earnings VS Forward Price EarningsHCXY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • HCXY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HCXY is cheaper than 70.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.84
HCXY Per share dataHCXY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of HCXY may justify a higher PE ratio.
PEG (NY)2.44
PEG (5Y)1.98
EPS Next 2Y3.42%
EPS Next 3Y-0.22%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. HCXY Dividend Analysis

5.1 Amount

  • HCXY has a Yearly Dividend Yield of 11.52%, which is a nice return.
  • HCXY's Dividend Yield is a higher than the industry average which is at 6.90.
  • HCXY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 11.52%

5.2 History

  • The dividend of HCXY is nicely growing with an annual growth rate of 6.10%!
  • HCXY has been paying a dividend for over 5 years, so it has already some track record.
  • HCXY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.1%
Div Incr Years0
Div Non Decr Years3
HCXY Yearly Dividends per shareHCXY Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 96.80% of the earnings are spent on dividend by HCXY. This is not a sustainable payout ratio.
  • HCXY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP96.8%
EPS Next 2Y3.42%
EPS Next 3Y-0.22%
HCXY Yearly Income VS Free CF VS DividendHCXY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M
HCXY Dividend Payout.HCXY Dividend Payout, showing the Payout Ratio.HCXY Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HCXY Fundamentals: All Metrics, Ratios and Statistics

HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33

NYSE:HCXY (4/2/2026, 8:04:00 PM)

24.81

-0.14 (-0.58%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-12
Earnings (Next)04-30
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners1.94%
Ins Owner ChangeN/A
Market Cap4.56B
Revenue(TTM)532.49M
Net Income(TTM)336.77M
Analysts82.67
Price Target34.93 (40.79%)
Short Float %0%
Short Ratio1.87
Dividend
Industry RankSector Rank
Dividend Yield 11.52%
Yearly Dividend1.85
Dividend Growth(5Y)6.1%
DP96.8%
Div Incr Years0
Div Non Decr Years3
Ex-Date04-15
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.03%
Min EPS beat(2)-4.39%
Max EPS beat(2)0.34%
EPS beat(4)2
Avg EPS beat(4)-1.26%
Min EPS beat(4)-5.01%
Max EPS beat(4)4.02%
EPS beat(8)2
Avg EPS beat(8)-1.97%
EPS beat(12)6
Avg EPS beat(12)0.56%
EPS beat(16)8
Avg EPS beat(16)0.88%
Revenue beat(2)1
Avg Revenue beat(2)-1.37%
Min Revenue beat(2)-2.99%
Max Revenue beat(2)0.25%
Revenue beat(4)2
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-4.12%
Max Revenue beat(4)3.19%
Revenue beat(8)3
Avg Revenue beat(8)-1.82%
Revenue beat(12)7
Avg Revenue beat(12)3.76%
Revenue beat(16)9
Avg Revenue beat(16)2.91%
PT rev (1m)0%
PT rev (3m)19.76%
EPS NQ rev (1m)-1.83%
EPS NQ rev (3m)-4.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.65%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)-0.23%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 12.92
Fwd PE 12.27
P/S 8.56
P/FCF N/A
P/OCF N/A
P/B 2.06
P/tB 2.06
EV/EBITDA 19.84
EPS(TTM)1.92
EY7.74%
EPS(NY)2.02
Fwd EY8.15%
FCF(TTM)-2.32
FCFYN/A
OCF(TTM)-2.32
OCFYN/A
SpS2.9
BVpS12.06
TBVpS12.06
PEG (NY)2.44
PEG (5Y)1.98
Graham Number22.83
Profitability
Industry RankSector Rank
ROA 7.35%
ROE 15.2%
ROCE 7.59%
ROIC 6%
ROICexc 6.07%
ROICexgc 6.08%
OM 64.17%
PM (TTM) 63.24%
GM 80.62%
FCFM N/A
ROA(3y)7.97%
ROA(5y)6.77%
ROE(3y)15.61%
ROE(5y)13.42%
ROIC(3y)6.67%
ROIC(5y)5.93%
ROICexc(3y)6.83%
ROICexc(5y)6.09%
ROICexgc(3y)6.85%
ROICexgc(5y)6.1%
ROCE(3y)8.44%
ROCE(5y)7.51%
ROICexgc growth 3Y6.57%
ROICexgc growth 5Y3.09%
ROICexc growth 3Y6.55%
ROICexc growth 5Y3.09%
OM growth 3Y3.15%
OM growth 5Y3.25%
PM growth 3Y26.79%
PM growth 5Y-4.23%
GM growth 3Y0.01%
GM growth 5Y1%
F-Score1
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Debt/EBITDA 6.68
Cap/Depr 26.41%
Cap/Sales 0.02%
Interest Coverage 4.09
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.55
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)214.85%
Cap/Depr(5y)145.57%
Cap/Sales(3y)0.12%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.48%
EPS 3Y9.06%
EPS 5Y6.52%
EPS Q2Q%-2.04%
EPS Next Y5.31%
EPS Next 2Y3.42%
EPS Next 3Y-0.22%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.44%
Revenue growth 3Y18.29%
Revenue growth 5Y13.13%
Sales Q2Q%12.85%
Revenue Next Year8.9%
Revenue Next 2Y7.05%
Revenue Next 3Y4.28%
Revenue Next 5YN/A
EBIT growth 1Y-15.62%
EBIT growth 3Y22.02%
EBIT growth 5Y16.82%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-258.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-260.58%
OCF growth 3YN/A
OCF growth 5YN/A

HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 / HCXY Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33?

ChartMill assigns a fundamental rating of 4 / 10 to HCXY.


What is the valuation status for HCXY stock?

ChartMill assigns a valuation rating of 4 / 10 to HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY). This can be considered as Fairly Valued.


What is the profitability of HCXY stock?

HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) has a profitability rating of 6 / 10.


What is the valuation of HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) is 12.92 and the Price/Book (PB) ratio is 2.06.


What is the earnings growth outlook for HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33?

The Earnings per Share (EPS) of HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) is expected to grow by 5.31% in the next year.